A coating method of Tosyl magnetic beads and its application in a kit

By using serine pretreatment liquid and suitable coating liquid components in the Tosyl bead coating method, the problem of magnetic bead clumping is solved, uniform dispersion and high reactivity of the magnetic beads are achieved, and the detection sensitivity of the kit is improved.

CN115343468BActive Publication Date: 2024-11-12NINGBO HAIER SHIZHI MFG CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210731642.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-06-24
Publication Date
2024-11-12
Estimated Expiration
2042-06-24

AI Technical Summary

Technical Problem

The existing Tosyl magnetic bead coating method often has clumping phenomenon, which affects its application in the kit. Especially at 37°C, pH 7.5-9.5, it is difficult to disperse the magnetic beads evenly.

Method used

Pretreatment is performed using a pretreatment solution containing serine, combined with the coating solution and blocking solution, and through components such as Tris, ammonium sulfate and Tween 20, the pH is adjusted to 9.5 to form a suitable hydrophilic environment to avoid the magnetic beads clumping together, and Wash and resuspend the PBS buffer to obtain the magnetic bead working fluid.

Benefits of technology

The uniform dispersion and good reactivity of Tosyl magnetic beads are achieved, so that the working liquid of the magnetic beads binds to alkaline phosphatase-labeled antibodies, and the sensitivity of reagent detection is improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115343468B_ABST
    Figure CN115343468B_ABST
Patent Text Reader

Abstract

The present invention relates to a coating method of Tosyl magnetic beads and an application thereof in a kit, belonging to the technical field of kits. The present invention discloses a coating method of Tosyl magnetic beads, characterized in that the coating method comprises: mixing and coating magnetic beads pretreated with a pretreatment liquid with antibodies in a coating liquid, then blocking with a blocking liquid, and then washing and resuspending with a PBS buffer to obtain a magnetic bead-coated antibody working solution; the pretreatment liquid comprises 3-6 mM Tris, 10-20 mM serine, 0.5-2 M ammonium sulfate, and a pH of 9.5.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of kits and relates to a coating method of Tosyl magnetic beads and application of the Tosyl magnetic beads in a kit. Background Art

[0002] Immunomagnetic beads (IMB), also known as immunomagnetic microspheres, are uniform, superparamagnetic and protective shell spherical particles, which are basically composed of carrier microspheres and immune ligands. Carrier microspheres mainly contain magnetic substances (small metal particles, such as iron oxide and ferroferric oxide, etc.) and polymer layers (such as polyethyleneimine, polyvinyl alcohol, polyacrylic acid, etc.). Common functional groups include tosyl magnetic beads, carboxyl magnetic beads, amino magnetic beads, epoxy magnetic beads, thiol magnetic beads, silicon-based magnetic beads, physical adsorption magnetic beads, etc., which make the surface have different physical properties such as hydrophobic-hydrophilic, non-polar-polar, positively charged-negatively charged. When the surface of immunomagnetic beads is tosyl, it is a hydrophobic magnetic bead, which is easier to agglomerate, mainly pointing to antibodies or antigens containing amino or thiol groups. The coating process needs to be carried out at 37°C and pH7.5-9.5. However, in the current coating method, the coating solution of Tosyl magnetic beads generally uses a boric acid system, and the reaction promoter is ammonium sulfate. The magnetic beads often clump before and after coating, which is not conducive to subsequent application in the kit. Summary of the invention

[0003] The purpose of the present invention is to solve the above problems in the prior art and propose a coating method for Tosyl magnetic beads pretreated with a pretreatment solution containing serine, so that the magnetic bead working solution has better dispersibility.

[0004] The object of the present invention can be achieved by the following technical scheme: a coating method of Tosyl magnetic beads, the coating method comprising: mixing and coating the magnetic beads pretreated with a pretreatment solution with antibodies in a coating solution, then blocking with a blocking solution, and then washing and resuspending with a PBS buffer to obtain a magnetic bead-coated antibody working solution;

[0005] The pretreatment solution includes 3-6 mM Tris, 10-20 mM serine, 0.5-2 M ammonium sulfate, and the pH is 9.5.

[0006] Preferably, the pretreatment solution comprises 5-6 mM Tris, 14-16 mM serine, and 0.8-1.2 M ammonium sulfate.

[0007] The amino acid selected in the pretreatment solution of the present invention can only be serine. The reason is that compared with glycine and threonine, the polar side chain amino acid serine has smaller steric hindrance and good hydrophilic effect. The side chain is easier to form hydrogen bonds with the toluenesulfonyl group on the surface of the magnetic beads. In a hydrophilic environment, the magnetic beads that are clustered due to hydrophobic effect become dispersed due to the action of serine.

[0008] Preferably, the coating solution comprises 10-20 mM Tris, 0.4-1 M ammonium sulfate, 0.05-0.2% Tween 20, and the pH is 9.5.

[0009] More preferably, the concentration ratio of Tris in the pretreatment solution and the coating solution is 1:(2-4).

[0010] More preferably, the concentration ratio of ammonium sulfate in the pretreatment solution and the coating solution is 1:(0.2-0.5).

[0011] Preferably, the blocking solution is a 50 mM Tris buffer with a pH of 7.4 containing 0.1-1% fish skin gelatin and 0.05-0.2% mannose.

[0012] Preferably, 0.3-0.6 mg of magnetic beads are added to every 100 μl of the pretreatment solution.

[0013] Preferably, the mass ratio of the magnetic beads to the antibodies is 100:(0.3-2).

[0014] Preferably, the concentration of the magnetic beads in the magnetic bead-coated antibody working solution is 3-5 mg / ml.

[0015] The invention also discloses an application of a Tosyl magnetic bead coating method in a kit.

[0016] The magnetic bead working solution prepared by the present invention is combined with the alkaline phosphatase labeled antibody working solution according to a conventional method to prepare a kit with high sensitivity.

[0017] Compared with the prior art, the present invention has the following beneficial effects:

[0018] 1. The pretreatment solution of the present invention can make the Tosyl magnetic beads evenly dispersed, which is beneficial to the subsequent reaction.

[0019] 2. Through the combined effects of the pretreatment solution, coating solution and blocking solution of the present invention, the magnetic bead working solution prepared by the present invention has good reactivity.

[0020] 3. The magnetic bead working solution prepared by the present invention can be combined with the alkaline phosphatase labeled antibody working solution to improve the detection sensitivity of the reagent. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 The microscope images are of the working solutions prepared in Examples 1, 4-6 and Comparative Examples 3-10 of the present invention.

[0022] Figure 2Microscope images of the magnetic bead working solutions prepared in Examples 11, 12, 14, 16, 18, 19, 21, 22, 34, 35, 36, 38, 40, and 42 of the present invention and Comparative Examples 11 and 12. DETAILED DESCRIPTION

[0023] The following are specific embodiments of the present invention, which further describe the technical solution of the present invention, but the present invention is not limited to these embodiments. Unless otherwise specified, the raw materials used in the present invention are all common materials available on the market; and the tests are carried out according to conventional testing methods.

[0024] Example 1

[0025] Resuspend 2.5 mg Tosyl magnetic beads with 500 ul pretreatment solution (PH 9.5) containing 5 mM Tris, 15 mM serine, and 1 M ammonium sulfate. After thorough mixing, place the centrifuge tube on a magnetic separation rack until the supernatant is completely transparent. Use a pipette to carefully discard the supernatant. Repeat the operation three times and mix on a blood mixer for 20 minutes.

[0026] Embodiment 2-10

[0027] Compared with Example 1, the difference is that the components in the pretreatment liquid are different, as shown in Table 1 below. The dispersibility in Examples 1-10 is good, and Example 1 is the best.

[0028] Embodiment 11

[0029] The solution pretreated by the pretreatment solution in Example 1 was immediately resuspended with a coating solution containing 15mMTris, 1M ammonium sulfate, and 0.1% Tween 20 to the target volume, and the antibody was added at a feeding ratio of 20ug / mg to the antibody and magnetic beads to fully mix, and a blood mixer was used to mix and coat for 20h at 37°C; After the reaction was completed, the centrifuge tube was placed on a magnetic separation rack until the supernatant was completely transparent, and the supernatant was carefully removed with a pipette, and 500ul of Tris blocking solution containing 5% fish skin gelatin pH 7.4 was added to fully mix, and the blood mixer was used to mix and block for 20h at 37°C; After the blocking was completed, the centrifuge tube was placed on a magnetic separation rack until the supernatant was completely transparent, and the supernatant was carefully removed with a pipette, and 0.1M containing 0.1% BSA was used to block the supernatant. Wash the magnetic beads with PBS buffer at pH 7.4, with a concentration of 5 mg / ml. Place the centrifuge tube on the magnetic separation rack until the supernatant is completely transparent. Use a pipette to carefully remove the supernatant. Repeat the wash twice and resuspend the magnetic beads with this buffer and store at 2-8°C. Observe the aggregation of the prepared magnetic bead working solution under an electron microscope. The results are as follows: Figure 1 shown.

[0030] Examples 12-24

[0031] Compared with Example 11, the difference lies in the different coating solution components, as shown in Table 2 below. Example 19 has the best comprehensive performance of reactivity and dispersibility, while Examples 14 and 15 have slightly poor reactivity due to excessive Tris concentration; in Examples 22-23, a lower pH is used, and the reactivity value is lower, and a higher pH is used, and the reactivity value is also lower, so the optimal value is 9.5.

[0032] Examples 25-33

[0033] Compared with Example 19, the difference is that the solution after pretreatment with the pretreatment liquid is Example 2-10. According to the dispersibility and reactivity data, it can be seen that the comprehensive performance of Examples 25-33 is still relatively good.

[0034] Examples 34-50

[0035] Compared with Example 11, the difference lies in the different sealing liquid components and feed ratios. In the selection of feed ratios, the ratio results obtained by different feed ratios of Examples 37, 40-42 are similar, but the background of Example 40 is lower, so it is better.

[0036] Examples 51-59

[0037] Compared with Example 40, the difference is that the solution after pretreatment with the pretreatment liquid is Example 2-10. According to the dispersibility and reactivity data, it can be seen that the comprehensive performance in Example 40 is still relatively good.

[0038] Comparative Example 1

[0039] Compared with Example 40, the difference is that the pretreatment solution is only 0.1M sodium borate solution at pH 9.5, the coating solution is 0.3-3M ammonium sulfate (0.1M boric acid) at pH 7.5-9.5, and the blocking solution is PBS solution at pH 7.4 containing 0.5% BSA. The performance is shown in Table 3.

[0040] Comparative Example 2

[0041] Compared with Example 40, the difference is that the pretreatment solution is a 0.1M sodium borate solution with a pH of 9.5. The performance is shown in Table 3.

[0042] Comparative Example 3

[0043] Compared with Example 1, the difference is that the amino acid is glycine.

[0044] Comparative Example 4

[0045] Compared with Example 1, the difference is that the amino acid is threonine.

[0046] Comparative Example 5

[0047] Compared with Example 1, the difference is that the concentration of ammonium sulfate in the pretreatment solution is 0.3 mM.

[0048] Comparative Example 6

[0049] Compared with Example 1, the difference is that the concentration of ammonium sulfate in the pretreatment solution is 3 mM.

[0050] Comparative Example 7

[0051] Compared with Example 1, the difference is that the concentration of Tris in the pretreatment solution is 1 mM.

[0052] Comparative Example 8

[0053] Compared with Example 1, the difference is that the concentration of Tris in the pretreatment solution is 10 mM.

[0054] Comparative Example 9

[0055] Compared with Example 1, the difference is that the buffer solution in the pretreatment solution is Hepes.

[0056] Comparative Example 10

[0057] Compared with Example 1, the difference is that the buffer solution in the pretreatment solution is Mops.

[0058] Comparative Example 11

[0059] Compared with Example 40, the difference is that the surfactant in the coating solution is Span 80.

[0060] Comparative Example 12

[0061] Compared with Example 40, the difference is that the surfactant in the coating solution is polyethylene glycol 400.

[0062] Table 1. Composition and performance of pretreatment liquid

[0063]

[0064] Table 2. Composition and properties of coating solution and blocking solution

[0065]

[0066] Table 3. Reactivity test table of different pretreatment processes

[0067]

[0068] According to Table 1, in the pretreatment solution of pH 9.5 including 3-6mMTris, 10-20mM serine, and 0.5-2M ammonium sulfate, the magnetic bead working solution has good dispersibility; in the coating solution of pH 9.5 including 10-20mMTris, 0.4-1M ammonium sulfate, and 0.05-0.2% Tween 20, the reactivity of the magnetic bead working solution is good; in the Tris blocking solution of 50mM pH 7.4 including 0.1-1% fish skin gelatin and 0.05-0.2% mannose, the reactivity of the magnetic bead working solution is good. Comparative Example 1 adopts a conventional coating method, and the dispersibility and reactivity are not good; Comparative Example 2 adopts a conventional pretreatment solution and only adopts the coating solution and blocking solution of the present invention, and does not adopt the pretreatment solution of the present invention. Compared with Comparative Example 1, the dispersibility and reactivity are improved to a certain extent, but are still lower than the dispersibility and reactivity in Example 1 of the present invention. The reactive ratio of the working fluid prepared in the present invention is greater than 12.5, and the background is kept at a slightly low level, and the agglomeration is good.

[0069] In summary, the coating method of the present invention can make Tosyl magnetic beads evenly dispersed in the working solution and have good reactivity.

[0070] The specific embodiments described herein are merely examples of the spirit of the present invention. Those skilled in the art may make various modifications or additions to the specific embodiments described or replace them in similar ways, but they will not deviate from the spirit of the present invention or exceed the scope defined by the appended claims.

Claims

1. A method for coating Tosyl magnetic beads, characterized in that: The coating method comprises: mixing and coating the magnetic beads pretreated with the pretreatment solution with the antibody in the coating solution, then blocking with the blocking solution, and then washing and resuspending with the PBS buffer to obtain the magnetic bead-coated antibody working solution; The pretreatment solution includes 3-6 mM Tris, 10-20 mM serine and 0.5-2 M ammonium sulfate, and the pH value is 9.

5.

2. The coating method according to claim 1, characterized in that The coating solution includes 10-20 mM Tris, 0.4-1 M ammonium sulfate and 0.05-0.2% Tween 20, and the pH value is 9.

5.

3. The coating method according to claim 2, characterized in that The ratio of Tris concentration in the pretreatment solution to that in the coating solution is 1:(2-4).

4. The coating method according to claim 2, characterized in that The ratio of the concentration of ammonium sulfate in the pretreatment solution to the concentration of ammonium sulfate in the coating solution is 1:(0.2-0.5).

5. The coating method according to claim 1, characterized in that The blocking solution is a 50mM Tris buffer with a pH of 7.4 containing 0.1-1% fish skin gelatin and 0.05-0.2% mannose.

6. The coating method according to claim 1, characterized in that The PBS buffer includes 0.1% BSA, the concentration of the PBS buffer is 0.01-0.2 M, and the pH is 7.

4.

7. The coating method according to claim 1, characterized in that Add 0.3-0.6 mg of magnetic beads per 100 μl of pretreatment solution.

8. The coating method according to claim 1, characterized in that The mass ratio of the magnetic beads to the antibodies is 100:(0.3-2).

9. The coating method according to claim 1, characterized in that: The concentration of the magnetic beads in the magnetic bead-coated antibody working solution is 3-5 mg / ml.

10. Use of the coating method of Tosyl magnetic beads as claimed in claim 1 in a kit.